These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6690042

  • 1. Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein.
    Barna BP, Deodhar SD, Gautam S, Yen-Lieberman B, Roberts D.
    Cancer Res; 1984 Jan; 44(1):305-10. PubMed ID: 6690042
    [Abstract] [Full Text] [Related]

  • 2. Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study.
    Gautam S, Deodhar S.
    J Biol Response Mod; 1989 Oct; 8(5):560-9. PubMed ID: 2795096
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ, Fidler IJ.
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [Abstract] [Full Text] [Related]

  • 5. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [Abstract] [Full Text] [Related]

  • 6. Macrophage tumoricidal activity induced by human C-reactive protein.
    Zahedi K, Mortensen RF.
    Cancer Res; 1986 Oct; 46(10):5077-83. PubMed ID: 3489521
    [Abstract] [Full Text] [Related]

  • 7. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ, Fogler WE, Kleinerman ES, Saiki I.
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein.
    Deodhar SD, James K, Chiang T, Edinger M, Barna BP.
    Cancer Res; 1982 Dec; 42(12):5084-8. PubMed ID: 7139613
    [Abstract] [Full Text] [Related]

  • 9. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I, Komuta K, Namba M, Yokota S, Ogura T, Kishimoto S.
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [Abstract] [Full Text] [Related]

  • 10. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S, Tachibana K, Shono M, Ogushi F, Tsubura E.
    J Biol Response Mod; 1984 Mar; 3(2):185-94. PubMed ID: 6726281
    [Abstract] [Full Text] [Related]

  • 11. Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein.
    Barna BP, Thomassen MJ, Wiedemann HP, Ahmad M, Deodhar SD.
    J Biol Response Mod; 1988 Oct; 7(5):483-7. PubMed ID: 3183685
    [Abstract] [Full Text] [Related]

  • 12. Therapy of spontaneous lung metastasis of murine renal adenocarcinoma by systemic administration of liposomes containing the macrophage activator CGP 31362.
    Dinney CP, Bucana CD, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ.
    Cancer Res; 1991 Jul 15; 51(14):3741-7. PubMed ID: 1905975
    [Abstract] [Full Text] [Related]

  • 13. Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
    Mace K, Mayhew E, Mihich E, Ehrke MJ.
    Cancer Res; 1988 Jan 01; 48(1):130-6. PubMed ID: 3257160
    [Abstract] [Full Text] [Related]

  • 14. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
    Fidler IJ, Barnes Z, Fogler WE, Kirsh R, Bugelski P, Poste G.
    Cancer Res; 1982 Feb 01; 42(2):496-501. PubMed ID: 7055801
    [Abstract] [Full Text] [Related]

  • 15. In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T lymphocytes and natural killer cells.
    Utsugi T, Dinney CP, Killion JJ, Brown D, Fidler IJ.
    Lymphokine Cytokine Res; 1991 Dec 01; 10(6):487-93. PubMed ID: 1804312
    [Abstract] [Full Text] [Related]

  • 16. Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide.
    Key ME, Talmadge JE, Fogler WE, Bucana C, Fidler IJ.
    J Natl Cancer Inst; 1982 Nov 01; 69(5):1198-98. PubMed ID: 6957661
    [Abstract] [Full Text] [Related]

  • 17. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ, Nacy CA, Hoover DL, Alving CR, Swartz GM, Meltzer MS.
    J Immunol; 1985 May 01; 134(5):3420-5. PubMed ID: 3980997
    [Abstract] [Full Text] [Related]

  • 18. Activation of human monocyte tumoricidal activity by C-reactive protein.
    Barna BP, James K, Deodhar SD.
    Cancer Res; 1987 Aug 01; 47(15):3959-63. PubMed ID: 3038302
    [Abstract] [Full Text] [Related]

  • 19. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE, Fidler IJ.
    Cancer Res; 1985 Jan 01; 45(1):14-8. PubMed ID: 3855280
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N, Schneider M.
    J Immunol; 1983 Feb 01; 130(2):974-80. PubMed ID: 6848604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.